Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > I see $20 per stock

<< Previous

Bullboard Posts

Next >>

Comment by fogduckkeron Jan 16, 2021 1:34am

356 Views

Post# 32312601

RE:I see $20 per stock

WEST-VAN-INVESTOR wrote:
1.6m type 1 cases in USA x $10000 avg cost per yr. x 25% of the market x 10% profit margin = $400 mil prof a year.

$400m prof per year / 208 m shares = $2. Prof per share per yr.

10% return. I see $20 stock.

But you are only talking about one application
there could be many more
sort of like valuing Amazon back in the day based on revenues from book sales

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide